Journave, the first non-addictive opioid-like pain medication, was developed based on Yale research from the ’90s.
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.
Suzetrigine, now marketed as Journavx, is not the first sodium-channel-targeting drug for pain management. Compounds such as procaine (Novocain) have provided reliable anaesthesia for more than a ...
14d
InsideHook on MSNNew FDA Approval Could Transform Pain ManagementIt’s become a familiar tragedy: someone is prescribed pain medication to recover from an injury, then becomes addicted to the medication intended to improve their life. It’s left both healthcare ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results